Despite these findings, very little is known about how circadian rhythm timing and fragmentation are associated with the pathological biomarkers of Alzheimer’s disease, amyloid-β (Aβ) and tau, in older adults, and how these relationships map onto cognition. The gene discussed is MAPT; the disease is Alzheimer disease.